 Latest Article
|
Protecting products versus platforms
Choosing an IP protection regime depends on the type of company you are building.
|
Latest Data Page
|
Academic partnerships 2015
|
SciCafé
|
Startups on the menu: Atreca
|
Trade Secrets Blog
|
The Bioentrepreneur blog, Trade Secrets, boasts contributors from around the globe, providing regular insight and commentary from those helping build the world's biotechnology sectors.
|
Podcast
|
The new episode of Nature Biotechnology's First Rounders podcast: Daniel Cohen is chairman and CEO of Pharnext. He was also co-founder of CEPH, Genethon and Millennium, and an early leader in the genomics field. His talk with Nature Biotechnology covers the industrialization of genomic sequencing, his part in founding Millennium and why the conductor has the most difficult job in an orchestra.
|
View more articles
|
Advertisement |
 |
BioPharma Dealmakers
A supplement to Nature Biotechnology and Nature Reviews Drug Discovery
Access the latest issue for updates on partnering opportunities with innovative biotech companies, and access cutting edge editorials on burgeoning therapeutic areas.
Download the issue for FREE | | | |
| |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our feedback department
Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston |
|
No comments:
Post a Comment